The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Open accessAbstract
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are interlinked through common risk factors, coincident in an ageing population, and are connected biologically through some deleterious effects of anticancer treatment on CV health. Anticancer therapies can cause a wide spectrum of short- and long-term cardiotoxic effects. An explosion of novel cancer therapies has revolutionised this field and dramatically altered cancer prognosis. Nevertheless, these new therapies have introduced unexpected CV complications beyond heart failure. Common CV toxicities related to cancer therapy are defined, along with suggested strategies for prevention, detection and treatment. This ESMO consensus article proposes to define CV toxicities related to cancer or its therapies and provide guidance regarding prevention, screening, monitoring and treatment of CV toxicity. The majority of anticancer therapies are associated with some CV toxicity, ranging from asymptomatic and transient to more clinically significant and long-lasting cardiac events. It is critical however, that concerns about potential CV damage resulting from anticancer therapies should be weighed against the potential benefits of cancer therapy, including benefits in overall survival. CV disease in patients with cancer is complex and treatment needs to be individualised. The scope of cardio-oncology is wide and includes prevention, detection, monitoring and treatment of CV toxicity related to cancer therapy, and also ensuring the safe development of future novel cancer treatments that minimise the impact on CV health. It is anticipated that the management strategies discussed herein will be suitable for the majority of patients. Nonetheless, the clinical judgment of physicians remains extremely important; hence, when using these best clinical practices to inform treatment options and decisions, practitioners should also consider the individual circumstances of their patients on a case-by-case basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the cumulative cisplatin dose, peak drug exposure, young age at treatment, co-administration of other ototoxic drugs and others are well-defined risk factors for more severe auditory damage 167,168,169 .”
From Osteosarcoma (2022) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citation2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Cited by
Sorted by citations
Items 401–500 of 999
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
Perpinia, A., Kadoglou, N. P. E., Vardaka, M., Gkortzolidis, G., Karavidas, A. I., Marinakis, T. P., Papachrysostomou, C., Makaronis, P., Vlachou, C., Mantzourani, M., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15081007 · Cited by 9
Palmieri, V., Vietri, M. T., Montalto, A., Montisci, A., Donatelli, F., Coscioni, E., & Claudio Napoli, A. (2023) · Cancers · doi:10.3390/cancers15082224 · Cited by 9
Koo, C. Y., Zheng, H., Tan, L. L., Foo, L.-L., Seet, R. C. S., Chong, J. H., Hausenloy, D. J., Chng, W. J., Richards, M., Lee, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00666-z · Cited by 9
Cardiovascular outcomes of cancer patients in rural Australia
Williams, T. D., Kaur, A., Warner, T., Aslam, M., Clark, V. L., Walker, R., Ngo, D. T. M., & Sverdlov, A. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1144240 · Cited by 8
Chang, W. H., & Lai, A. G. (2024) · Scientific Reports · doi:10.1038/s41598-024-51161-0 · Cited by 8
Ogilvie, L. M., Coyle‐Asbil, B., Brunt, K. R., Petrik, J., & Simpson, J. A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2023 · Cited by 9
EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring
Wang, Y., Qiu, Q., Deng, X., & Wan, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1426796 · Cited by 8
Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
Onoue, T., Matthews, A. H., Vakilpour, A., Kang, Y. M., Lefebvre, B., Smith, A. M., McCurdy, S. R., Fradley, M. G., Carver, J. R., Chittams, J. L., et al. (2024) · Cardio-Oncology · doi:10.1186/s40959-024-00275-5 · Cited by 8
Self-citationCardiovascular Health Considerations for Primary Care Physicians Treating Breast Cancer Survivors
Kidane, R. D., Ruddy, K. J., Lin, G. R., & Sandhu, N. P. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.08.014 · Cited by 8
Atrial fibrillation in cancer patients: Epidemiology, identification and management
Yu, C., Jiang, L., Long, L., & Yu, H. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.006 · Cited by 8
Chen, G., Zhou, H., Wang, C., Qin, R., Yang, Q., Hou, Y., Zhang, M., Zhang, C., Wang, N., & Feng, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1502361 · Cited by 8
Haghmorad, D., Razavi, F. T., Eivazzadeh, Y., Yazdanpanah, E., & Orooji, N. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118364 · Cited by 8
2025 Clinical practice guidelines for Myocarditises
Arutyunov, G. P., Драгунов, Д. О., Жиров, И. В., Моисеева, О. М., Палеев, Ф. Н., Sokolova, A. V., Apkhanova, T. V., Arutyunov, A. G., Blagova, O. V., Габрусенко, С. А., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6458 · Cited by 10
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
Bisceglia, I., Gabrielli, D., Canale, M. L., Gallucci, G., Parrini, I., Turazza, F. M., Russo, G., Maurea, N., Quagliariello, V., Lestuzzi, C., et al. (2021) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab067 · Cited by 8
Bansal, N., Hazim, C. F., Badillo, S., Shyam, S., Wolfe, D. S., Bortnick, A. E., Garcia, M. J., Rodríguez, C. J., & Zhang, L. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110373 · Cited by 8
Viamonte, S., Joaquim, A. V., Alves, A. J., Vilela, E., Capela, A., Ferreira, C., Costa, A. J., Teixeira, M., Duarte, B., Rato, N. D., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07638-1 · Cited by 8
Coles, B., Welch, C. A., Motiwale, R. S., Teece, L., Oliver‐Williams, C., Weston, C. F. M., de Belder, M., Lambert, P. C., Rutherford, M. J., Paley, L., et al. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad020 · Cited by 8
Self-citationCardio-Oncologic Knowledge of Nurses in the Oncology Service: A Multi-Center Survey in China
Zhang, C., Yang, Z., Du, R., Feng, Y., Zhang, X., & Zhang, J. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s436376 · Cited by 8
Ma, L., Wang, Q., Li, X., Shang, Y., Zhang, N., Wu, J., Liang, Y., Chen, G., Tan, Y., Liu, X., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-11847-0 · Cited by 8
Chen, W., Xie, J., Gao, C., Zhang, C., Fu, Z., & Chen, S. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.01.012 · Cited by 8
Ou, W., Jiang, T., Zhang, N., Lü, K., Weng, Y., Zhou, X., Wang, D., Dong, Q., & Tang, X. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-074541 · Cited by 8
Case series, chemotherapy-induced cardiomyopathy: mind the family history!
Moghadasi, S., Fijn, R. D., Beeres, S. L. M. A., Bikker, H., Jongbloed, J. D. H., Jitta, D. J., Kroep, J. R., Deprez, R. H. L., Vos, Y. J., de Vreede, M. J. M., et al. (2021) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytab333 · Cited by 8
Cardiac Computed Tomography-Derived Myocardial Tissue Characterization After Anthracycline Treatment
Egashira, K., Sueta, D., Kidoh, M., Tomiguchi, M., Oda, S., Usuku, H., Hidaka, K., Goto‐Yamaguchi, L., Sueta, A., Komorita, T., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13867 · Cited by 8
Cui, W., Phillips, K., Francis, P. A., Anderson, R. A., Partridge, A. H., Loi, S., Loibl, S., & Keogh, L. A. (2022) · The Breast · doi:10.1016/j.breast.2022.05.002 · Cited by 9
Xiao, D., Li, J., Liu, Y., Wang, T., Niu, C., Zhuang, R., Liu, B., Ma, L., Li, M., & Zhang, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1089916 · Cited by 8
Real-World Evidence in Cardio-Oncology
Ohtsu, H., Shimomura, A., & Sase, K. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.02.002 · Cited by 8
Tailored to a Woman’s Heart: Gender Cardio-Oncology Across the Lifespan
Chen, M. H., & Epstein, S. F. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01967-7 · Cited by 10
Leo, I., Vidula, M. K., Bisaccia, G., Procopio, M. C., Licordari, R., Perotto, M., Vecchia, G. L., Miaris, N., Bravo, P. E., & Bucciarelli‐Ducci, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154945 · Cited by 8
Belenkov, Y. N., Ilgisonis, I. S., Khabarova, N. V., & Kirichenko, Y. Y. (2024) · Kardiologiia · doi:10.18087/cardio.2024.8.n2753 · Cited by 7
Tavernese, A., Cammalleri, V., Mollace, R., Antonelli, G., Piscione, M., Cocco, N., Carpenito, M., Dominici, C., Federici, M., & Ussia, G. P. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12010009 · Cited by 8
Zhang, S. C., Kehayias, C. E., Guthier, C. V., He, J., Gasho, J. O., Kozono, D., Nohria, A., Nikolova, A., Mak, R. H., & Atkins, K. M. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2025.06.3852 · Cited by 7
Obispo, B., Bailleux, C., Cantos, B., Zamora, M. P., Jhawar, S. R., Varghese, J. S., Cabal‐Hierro, L., Luz, P., Berrocal-Almanza, L. C., & Xu, X. (2025) · Cancers · doi:10.3390/cancers17152506 · Cited by 7
Stefanou, E., Tsitsinakis, G., Karageorgou, D., & Kole, C. (2025) · Cancers · doi:10.3390/cancers17172838 · Cited by 9
Mo, Y., Tian, B., Wu, M. Y., Chen, M., Chen, D., & Yu, J. (2022) · Cancer Medicine · doi:10.1002/cam4.4948 · Cited by 7
Cardio-oncology: Understanding the different mechanisms of cardiovascular toxicity
Toste, J. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.04.011 · Cited by 7
Possible heart failure caused by osimertinib in a lung cancer patient
Ruiz-Briones, P., Escudero‐Vilaplana, V., Collado‐Borrell, R., Vicente-Valor, J., Alvarez, R. M., Villanueva‐Bueno, C., Narrillos-Moraza, Á., Herranz, A., & Sanjurjo‐Sáez, M. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221143787 · Cited by 7
Cardioprotective effect of thiotriazoline in cancer patients
Koltsov, A. V., & Tyrenko, V. V. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5304 · Cited by 7
Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
Peix, A., Barreda, A. P., & Pérez, A. M. B. (2023) · European Cardiology Review · doi:10.15420/ecr.2022.36 · Cited by 7
Current Management Options for Dyspnea in Cancer Patients
Mori, M., Miwa, S., Ikari, T., Kako, J., Hasegawa, T., Matsunuma, R., Suzuki, K., Matsuda, Y., Watanabe, H., Morita, T., et al. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01081-4 · Cited by 7
Yuan, F., Lenneman, C., Krone, R. J., Williams, G. R., Outlaw, D. A., Katsnelson, M. J., & Lirette, S. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2896 · Cited by 7
Self-citationYang, L., Liu, X., Yang, W., Wang, S., Li, Z., Lei, Y., & Liu, D. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103053 · Cited by 7
Seth, L., Makram, O. M., Essa, A., Patel, V., Jiang, S. M., Bhave, A. H., Yerraguntla, S., Gopu, G., Malik, S., Swaby, J. D., et al. (2024) · Advances in Radiation Oncology · doi:10.1016/j.adro.2024.101583 · Cited by 7
Self-citationRaghuvanshi, S. S., Arya, K. V., & Patel, V. (2024) · International Journal of Electrical and Electronics Research · doi:10.37391/ijeer.120343 · Cited by 7
Marrazzo, L., Meattini, I., Becherini, C., Salvestrini, V., Visani, L., Barletta, G., Saieva, C., Bene, M. R. D., Pilato, G., Desideri, I., et al. (2024) · La radiologia medica · doi:10.1007/s11547-024-01897-6 · Cited by 7
Zhang, C.-R., Shen, G., Li, S., Ma, F., Li, H., Tang, Y., Li, Y., Li, Z., Zhu, Z., Qiu, T., et al. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00709-6 · Cited by 7
Cardiology consultation in oncology practice: a 5-year survey
Tajiri, K., Sekine, I., Naito, H., Murata, M., Li, S., Inoue, K., Sasamura, R., Nakajima, H., Iida, N., Nagashio, K., et al. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa118 · Cited by 7
A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients
Mangone, L., Mancuso, P., Tarantini, L., Larocca, M., Bisceglia, I., Damato, A., Rossi, P. G., Navazio, A., & Pinto, C. (2021) · Cancers · doi:10.3390/cancers13235903 · Cited by 7
Bouwer, N. I., Steenbruggen, T. G., Rier, H. N., Kitzen, J. J. E. M., Smorenburg, C. H., van Bekkum, M. L., de Jong, P. C., Drooger, J. C., Holterhues, C., Kofflard, M. J. M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34024 · Cited by 7
Xiao, W. L., Ma, L., Shang, Y., Yang, F., Tan, Y., Chen, G., Wu, J., Liang, Y., Rouzi, T., Wang, Q., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.844350 · Cited by 7
Comparison of American and European guidelines for cardio-oncology of heart failure
Chen, J.-Z., & Liang, B. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10304-7 · Cited by 7
Tamura, Y., & Tamura, Y. (2023) · Pharmaceuticals · doi:10.3390/ph16091297 · Cited by 7
Yu, C., Negishi, T., Pathan, F. K., Sverdlov, A. L., Thomas, L., Shirazi, M., Koo, C. Y., Tan, L. L., Miyazaki, S., & Negishi, K. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.10.004 · Cited by 7
Robustness of [18F]FDG PET/CT radiomic analysis in the setting of drug-induced cardiotoxicity
Palomino-Fernández, D., Seiffert, A. P., Gómez‐Grande, A., López-Guarch, C. J., Moreno, G., Bueno, H., Aguilera, E. J. G., & González, P. S. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107981 · Cited by 7
Tanaka, Y., Tanaka, H., Hatazawa, K., Yamashita, K., Sumimoto, K., Shono, A., Suzuki, M., Yokota, S., Suto, M., Mukai, J., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.019 · Cited by 7
Seiffert, A. P., Gómez‐Grande, A., Leal, G. C., Rodríguez, A., Palomino-Fernández, D., Aguilera, E. J. G., González, P. S., & Bueno, H. (2021) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-021-02508-9 · Cited by 7
Ghignatti, P. V. D. C., Russo, M. K. B., Becker, T., Guecheva, T. N., Teixeira, L. V., Lehnen, A. M., Schaun, M. I., & Leguisamo, N. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-09361-z · Cited by 7
Cho, I., You, S. C., Cha, M. J., Hwang, H., Cho, E. J., Kim, H. J., Park, S., Kim, S.-E., Lee, Y., Youn, J., et al. (2024) · Journal of Cardiovascular Imaging · doi:10.1186/s44348-024-00014-5 · Cited by 10
de Moraes, F. C. A., Sano, V. K. T., Dantas, C. R., Hoffmeister, N., Kelly, F. A., & Burbano, R. M. R. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03772-2 · Cited by 7
Abdelnabi, M. H., Ibrahim, R., Pham, H. N., Heon, B. J., Bcharah, G., Pathangey, G., Pereyra, M., Farina, J., Chang, I. C., Arsanjani, R., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15060224 · Cited by 6
Liu, R., Fan, C., Liu, X., Li, M., Zhang, Y., & Zhang, M. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00332-7 · Cited by 6
Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity
Cha, Y.-J., Jeon, S., Lee, C. J., Kim, H., Lee, S., Kim, H., Park, S. H., Chen, E. Z., Kim, J. W., Park, S. W., et al. (2025) · Antioxidants · doi:10.3390/antiox15010027 · Cited by 6
Chen, K., An, Y., Wang, Z., & Nie, F. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1707889 · Cited by 6
CARDIOTOXICITY RISK PREDICTION IN BREAST CANCER PATIENTS
Kozhukhov, S., Dovganych, N., Smolanka, I. I., Lygyrda, O. F., Bazyka, O., Lyalkin, S. A., Ivankova, O. M., Yarinkina, O., & Tkhor, N. V. (2021) · Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology · doi:10.33145/2304-8336-2021-26-498-512 · Cited by 6
Park, C., Han, S., Litten, K. P., Mehta, S., & Ng, B. P. (2023) · Chronic Illness · doi:10.1177/17423953231196613 · Cited by 6
Home-based self-management multimodal cancer interventions & cardiotoxicity: a scoping review
Talty, A., Morris, R., & Deighan, C. (2024) · Cardio-Oncology · doi:10.1186/s40959-024-00204-6 · Cited by 6
Rosenfeld, R., Riondino, S., Cerocchi, M., Luciano, A., Idone, G., Lecis, D., Illuminato, F., Tolomei, A., Torino, F., Chiocchi, M., et al. (2024) · The Breast · doi:10.1016/j.breast.2024.103755 · Cited by 6
Cardiotoxicity in Breast Cancer: Impact of Clinical Classifications and Treatment on Heart Health
Murg, S. I., Matiș, L., Moldovan, A. F., Schwarz-Madar, A. F., Trifan, D. F., Ghitea, T. C., & Popescu, M. I. (2024) · Cancers · doi:10.3390/cancers16244281 · Cited by 6
Trapani, D., Jin, Q., Miller, K. D., Rugo, H. S., Reeder-Hayes, K. E., Traina, T. A., Abdou, Y. G., Falkson, C. I., Abramson, V. G., Ligibel, J. A., et al. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.12.018 · Cited by 6
A novel approach to the prevention and management of chemotherapy-induced cardiotoxicity: PANoptosis
Meng, C., Wang, Y., Zheng, T., Rong, Z., Lv, Z., Wu, C., Zhou, X., & Mao, W. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111379 · Cited by 6
Hedayati, E., Papakonstantinou, A., Månsson‐Broberg, A., Bergh, J. C. S., Hűbbert, L., & Altena, R. (2020) · Cardio-Oncology · doi:10.1186/s40959-020-00070-y · Cited by 6
Ashariati, A., Suryantoro, S. D., Savitri, M., Hendrata, W. M., Wijaya, A. Y., & Pikir, B. S. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.017 · Cited by 6
CAR T Cell and BiTE Therapy—New Therapies, New Risks?
Chen, D. H., Tyebally, S. M., Mallouppas, M., & Ghosh, A. K. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-00661-5 · Cited by 6
Perone, F., Auñón, P., Rodríguez, L., Viñal, D., Caro‐Codón, J., Pertejo, A., Marín, V. M., Espinosa, E., & López‐Fernández, T. (2022) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2022.2163 · Cited by 6
Liu, X., Tao, L., Wang, M., Li, H., & Xu, W. (2022) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.10.010 · Cited by 6
Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
Luo, L., Liu, Y., Lu, J., Zhang, Y., Fan, G., Tang, X., & Guo, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1104888 · Cited by 6
Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
Lluch-Gómez, J., Núñez-Álvarez, V., de la Torre-Hita, C., Bernal-Gómez, M., Campini-Bermejo, A., Perdomo-Zaldívar, E., Rodríguez-Pérez, L., Calvete-Candenas, J., Bautista, M. J. M., Benítez‐Rodríguez, E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34429-9 · Cited by 6
Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients
Battisha, A., Sawalha, K., Obeidat, Y., & Patel, B. D. (2023) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000314 · Cited by 6
Knowles, R., Kemp, E., Miller, M., & Koczwara, B. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01468-0 · Cited by 6
Lipid Disturbances in Breast Cancer Patients during Chemotherapy
Aliberti, A., Alikari, V., Tsironi, M., Gil, A. P. R., Papageorgiou, D., Kolovos, P., Παναγιώτου, Α., Panoutsopoulos, G. I., Lavdaniti, M., & Zyga, S. (2023) · Nursing Reports · doi:10.3390/nursrep13040126 · Cited by 6
Tan, S., Nelson, A. J., Muthalaly, R. G., Ramkumar, S., Hamilton, J., Nerlekar, N., Segelov, E., & Nicholls, S. J. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae204 · Cited by 6
Adusumalli, S., Alvarez-Cardona, J. A., Khatana, S. A. M., Mitchell, J. D., Blaes, A. H., Casselli, S., O’Quinn, R. P., & Lenihan, D. J. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10010-x · Cited by 6
Self-citationLópez‐Fernández, T. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10028-1 · Cited by 6
Cancer Therapy and the Heart; The Necessity to Calibrate Risk
Okwuosa, T. M., Keramida, K., Filippatos, G. S., & Yancy, C. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1999 · Cited by 6
Marinko, T., Konda, J. T. S., Dolžan, V., & Goričar, K. (2020) · Disease Markers · doi:10.1155/2020/6645588 · Cited by 6
Cardio-oncology Training in the COVID-19 Era
Feldman, S. A., Liu, J., Steingart, R. M., & Gupta, D. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00855-y · Cited by 6
Lee, S. F., Vellayappan, B. A., Wong, L. C., Chiang, C., Chan, S. K., Wan, E. Y. F., Wong, I. C. K., Lambert, P. C., Rachet, B., Ng, A. K., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2021.100363 · Cited by 6
Hou, P.-Y., Hsieh, C.-H., Wu, L.-J., Hsu, C., Kuo, D., Lu, Y.-F., Wu, Y., Tien, H., Hsu, S., & Shueng, P. (2022) · Bioengineering · doi:10.3390/bioengineering9050213 · Cited by 6
Cardiogenic shock among cancer patients
Curtiaud, A., Delmas, C., Gantzer, J., Zafrani, L., Siegemund, M., Meziani, F., & Merdji, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.932400 · Cited by 7
Fiúza, M., Magalhães, A., Menezes, M. N., Costa, P., Ribeiro, L., Abreu, C., Lopes-Brás, R., Vieira, J., Duarte, A. I., Morais, P., et al. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.07.014 · Cited by 6
Lal, J. C., Fang, M. Z., Hussain, M., Abraham, A., Tonegawa‐Kuji, R., Hou, Y., Chung, M. K., Collier, P. H., & Cheng, F. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00309-6 · Cited by 5
Lenihan, D. J., Whayne, J. G., Osman, F., Rivero, R., Montenbruck, M., Schwarz, A. K., Kelle, S., Wülfing, P., Dent, S. F., André, F., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15151948 · Cited by 5
Self-citationShah, V., Panchal, V. S., Shah, A., Vyas, B., Bhowmik, S., Panchal, I., & Jain, P. (2025) · Medicine International · doi:10.3892/mi.2025.268 · Cited by 5
Tamburrini, G., García, C. D. C., & López‐Fernández, T. (2025) · European Cardiology Review · doi:10.15420/ecr.2025.26 · Cited by 5
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors
Fanaroff, A. C., Orr, J. A., Anucha, C., Kim, E., Rareshide, C. A. L., Zhu, J., Echevarria, M., Rodarte, S., Kassabian, M., Balasian, E., et al. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.10.001 · Cited by 5
Self-citationJang, K. H., Wallins, J. S., Lin, I., Movva, S., Tap, W. D., Liu, J. E., & Yu, A. F. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf370 · Cited by 5
Şahin, M., Kazaz, S. N., Kartaler, F., Kodal, B., Altuntaş, S., Yüce, E., Turan, O. E., & Kutlu, M. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09841-w · Cited by 5
Szmit, S., Długosz‐Danecka, M., Drozd-Sokolowska, J. E., Joks, M., Szeremet, A., Jurczyszyn, A. J., & Jurczak, W. J. (2024) · Heart Lung and Circulation · doi:10.1016/j.hlc.2024.03.003 · Cited by 5
Orleanska, J., Bik, E., Barańśka, M., & Majzner, K. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124623 · Cited by 5
Sacha, T., & Krawczyk, K. (2024) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2024.04.124 · Cited by 5
Torresan, S., Bortolot, M., Carlo, E. D., Bertoli, E., Stanzione, B., Conte, A. D., Spina, M., & Bearz, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020554 · Cited by 6
Metadata
- Authors
- Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M. G., Orecchia, R., de Azambuja, E., Zamorano, J. L., Krone, R., Iakobishvili, Z., Carver, J., Armenian, S., Ky, B., Cardinale, D., Cipolla, C. M., Dent, S., & Jordan, K.
- Affiliations
- University of Milan (IT)
- Washington University Medical Center (US)
- University of South Florida (US)
- Lahey Hospital and Medical Center (US)
- Georgetown University (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- University of Kansas Medical Center (US)
- Royal Brompton Hospital (GB)
- Centre Hospitalier Universitaire de Liège (BE)
- University of Chicago (US)
- Vanderbilt University (US)
- Stanford Medicine (US)
- European Institute of Oncology (IT)
- Hospital Universitario Ramón y Cajal (ES)
- Washington University in St. Louis (US)
- Tel Aviv University (IL)
- Hospital of the University of Pennsylvania (US)
- City Of Hope National Medical Center (US)
- University of Pennsylvania (US)
- Duke University (US)
- Heidelberg University (DE)
- ORCID
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 171-190
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC8019325
- OpenAlex
- W2999536665
- Cited by
- 1,031
- References
- 221
- Citations by year
- 2026: 108 · 2025: 152 · 2024: 168 · 2023: 189 · 2022: 188 · 2021: 143 · 2020: 83
- FWCI
- 93.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- HF
- Genentech
- Amgen
- Servier
- Pfizer
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- cardio-oncology, cardiotoxicity, cancer therapy, heart failure, cardiovascular screening, cardiovascular monitoring, novel cancer therapies, cardiovascular disease in cancer patients
- MeSH terms
- Antineoplastic Agents, Heart Diseases, Humans, Medical Oncology, Neoplasms, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
